Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
12/2007
12/18/2007US7309714 Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
12/18/2007CA2268077C 1,3-bis-(n-lactamyl) propane and the pharmaceutical and cosmetic use thereof
12/13/2007WO2007142253A1 2-cyanopyrrolidine derivative
12/13/2007WO2007142140A1 Method for producing curing agent having acidic substituent and unsaturated maleimide group, thermosetting resin composition, prepreg, and laminate
12/13/2007WO2007142028A1 Pyrrolidine analogue for preventing neurogenic pain and method for production thereof
12/13/2007WO2007141343A1 Phenyl pyrrole aminoguanidine derivatives
12/13/2007WO2007141039A1 1,3-disubstituted 4-methyl-1h-pyrrole-2-carboxamides and their use for the manufacture of medicaments
12/13/2007WO2007141009A1 N- (l-alkyl-2- phenylethyl) -carboxamide derivatives and use thereof as fungicides
12/13/2007WO2007141002A1 Co-crystals of pyrrolidinones
12/13/2007WO2007140881A1 Alkoxyalkyl-substituted cyclic keto-enols
12/13/2007WO2007113575A3 Reagents and methods for cross-linking biological molecules
12/13/2007WO2007080470A3 A method for the purification of levetiracetam
12/13/2007US20070287743 Adamantyl Pyrrolidin-2-One Derivatives as 11-Beta Hydroxtsteroid Dehydrogenase Inhibitors
12/13/2007US20070286842 serine protease inhibitors, for the treatment of hepatitis c virus infections
12/13/2007CA2688485A1 Phenyl pyrrole aminoguanidine derivatives
12/13/2007CA2654784A1 Substituted phenylacetic acids as dp-2 antagonists
12/13/2007CA2653526A1 1,3-disubstituted 4-methyl-1h-pyrrole-2-carboxamides and their use for the manufacture of medicaments
12/13/2007CA2653520A1 N- (l-alkyl-2- phenylethyl) -carboxamide derivatives and use thereof as fungicides
12/12/2007EP1864972A1 Bcrp/abcg2 inhibitor
12/12/2007EP1864971A1 Prophylactic/therapeutic agent for diabetes
12/12/2007EP1863871A1 Rubber composition comprising an itaconimido-maleimide
12/12/2007EP1863804A1 Inhibitors of histone deacetylase
12/12/2007EP1863800A2 Synthesis of avrainvillamide, stephacidin b, and analogues thereof
12/12/2007EP1863761A1 Process for preparing levetiracetam
12/12/2007EP1863748A1 Methods for carbon isotope labeling synthesis by transition metal-promoted carbonylation via isocyanate using azides and carbon-isotope monoxide
12/12/2007EP1863477A1 3,4-substituted pyrrolidine derivatives for the treatment of hypertension
12/12/2007EP1725526B1 Method for preparing pyrrolidine oximes
12/12/2007CN101087778A Pyrrolidyl derivatives of heteroaromatic compounds as phosphodiesterase inhibitors
12/12/2007CN101087757A Novel dipeptidyl peptidase iv inhibitors, process for their preparation and compositions containing them
12/12/2007CN101087756A 肽酶抑制剂 Peptidase inhibitors
12/12/2007CN101087752A Novel ligands that modulate RAR receptors, and use thereof in human medicine and in cosmetics
12/12/2007CN100353942C Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof
12/11/2007US7307169 Isotopically enriched N-substituted piperazines and methods for the preparation thereof
12/11/2007US7307140 Prepared by reacting a polyether amine (Jeffamine T-3000) with a maleimide; binders for two-component polyurethane coating compositions; longer pot life; hard coatings; less of a tendency to form hydantoin rings
12/11/2007US7307044 Use as insecticides, fungicides and/or herbicides; e.g. 3-(2-methyl-5-(4-chloro-phenyl)phenyl)-3-chloro-5,5-dimethyl-pyrrolidin-2,4-dione
12/06/2007WO2007140197A1 Therapeutic pyrrolidine compounds
12/06/2007WO2007139215A1 Production method of heterocyclic mercapto compound
12/06/2007WO2007138352A1 Zofenopril calcium
12/06/2007WO2007137925A1 Hydroxylated amide skin moisturizer
12/06/2007WO2007118873A3 Polymorphs of atorvastatin sodium and magnesium salts
12/06/2007WO2007118185A3 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
12/06/2007WO2007107008A8 Compounds and compositions for use in the prevention and treatment of disorders of fat metabolism and obesity
12/06/2007WO2007105053A3 Tetralines antagonists of the h-3 receptor
12/06/2007WO2007064842A3 Synthesis of chlorins and phorbines with enhanced red spectral features
12/06/2007US20070282107 Reacting n-protected-3-cyano-4-oxo-pyrrolidine with with alkoxyamine or haloalkoxyamine in the presence of a base, reacting with methanesulfonic acid, adding methanesulfonic acid and hydrogenation catalyst, hydrogenation reaction
12/06/2007US20070282100 Boronic ester and acid compounds, synthesis and uses
12/06/2007US20070281981 Therapeutic compounds
12/06/2007US20070281976 Such as 1-(2,6-Dichloro-4-trifluoromethylphenyl)-2,3-dicyano-4-trifluoromethylsulfinyl-5-N-methyl-N-(2-methylthioethyl)aminopyrrole
12/06/2007US20070281369 Acousto-Mechanical Detection Systems and Methods of Use
12/06/2007DE102006025874A1 Alkoxyalkyl-substituierte cyclische Ketoenole Alkoxyalkyl-substituted cyclic ketoenols
12/06/2007CA2653223A1 Therapeutic pyrrolidine compounds
12/05/2007EP1862457A2 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
12/05/2007EP1862456A1 Process for producing carbapenem derivative having 1-alkylpyrrolidine structure
12/05/2007EP1862442A1 Process for oxidation of organic compounds
12/05/2007EP1861384A1 11-beta-hydroxysteroid dehydrogenase inhibitors
12/05/2007EP1861374A1 Carboxanilides as microbiocides
12/05/2007EP1861365A1 N-sulphonylpyrroles and their use as histone deacetylase inhibitors
12/05/2007EP1861364A1 Preparation of an atorvastatin intermediate using a paal-knorr condensation
12/05/2007EP1861363A1 Method of preparation of pure 4-pyrrolidinophenylbenzyl ether derivatives as maob inhibitors
12/05/2007EP1861362A1 Method for preparing enantiomerically pure 4-pyrrolidinophenyl, benzyl, ether derivatives
12/05/2007EP1861361A1 Glycopyrronium salts and their therapeutic use
12/05/2007EP1861360A1 Pyrrolidine derivatives as histamine h3 receptor antagonists
12/05/2007EP1861097A1 Mitotic kinesin inhibitors
12/05/2007EP1492876B1 Cationic amphiphiles for intracellular delivery of therapeutic molecules, composition, process and use thereof
12/05/2007EP1399420B1 Pyrrolidines as dipeptidyl peptidase inhibitors
12/05/2007EP1169294B1 Pharmaceutical compounds
12/05/2007CN101084216A Inhibitors for the soluble epoxide hydrolase
12/05/2007CN101084188A Method for producing pyrrolidones from succinates from fermentation broths
12/05/2007CN101084184A Cycloalkylamine derivatives
12/05/2007CN101081845A Substituted sulphone and sulphonamide compounds useful for the treatment of obesity, type II diabetes and cns disorders
12/05/2007CN100352819C Novel compounds as NS3-serine protease inhibitors of hepatitis c virus
12/05/2007CN100352815C Phosphorescence compound and electro field light emitting device having the same
12/05/2007CN100352503C Drug for preventing vascular restenosis and instrument to be embedded in vessel coated with the drug
12/04/2007US7304167 Biphenylcarboxamides useful as lipid lowering agents
12/04/2007US7304166 (2S,4S)-2-Cyano-4-fluoro-1-[(2-hydroxy-1,1-dimethyl)ethylamino]acetylpyrrolidine benzenesulfonate; dipeptidyl peptidase IV inhibitors with high-purity uniform crystal form and excellent solid-state stability
12/04/2007US7304165 Combination libraries
12/04/2007US7304088 Peptide like compounds for treating coronavirus or hepatitis C virus; severe acute respiratory distress syndrome
12/04/2007US7304087 1-acyl-pyrrolidine derivatives for the treatment of viral infections
12/04/2007US7304083 2-iminoimidazole derivatives (2)
12/04/2007US7304081 Cycloalkylcarbonyl-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-ones: 1'-{[1-(4-Chlorophenyl)cyclo-pentyl]carbonyl}-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-one; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents
12/04/2007US7304053 Glycoprotein-mediated MDR
12/04/2007CA2424964C Nitrogen-containing 5-membered ring compound
11/2007
11/29/2007WO2007136668A2 N-benzoyl-and n-benzylpyrrolidin-3-ylamines as histamine-3 antagonists
11/29/2007WO2007135294A2 2-alkoxy-3,4,5-trihydroxy-alkylamide-benzothiazepines, the preparation and use thereof, and compositions containing the same
11/29/2007WO2007134799A1 Novel microbiocides
11/29/2007WO2007120647A3 Compositions useful as inhibitors of voltage-gated sodium channels
11/29/2007WO2007117557A3 Diaminopropanol renin inhibitors
11/29/2007WO2007104781A3 Method for manufacturing of r-enantiomer of n-carbamoylmethyl-4-phenyl-2-pyrrolidone
11/29/2007WO2007104780A3 N- carbamoylmethyl- 4- (r) -phenyl-2-pyrr0lidin0ne, method of its preparation and pharmaceutical use
11/29/2007WO2007076158A3 Processes for preparing darifenacin hydrobromide
11/29/2007WO2007035722A8 Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration
11/29/2007US20070276145 Method of Preparing a Ring Compound Having Two Adjacent Chiral Centers
11/29/2007US20070276142 Catalytic Asymmetric Synthesis of Optically Active Alpha-Halo-Carbonyl Compounds
11/29/2007US20070276138 Modulators of peroxisome proliferator activated receptors
11/29/2007US20070276028 Pesticidal n-phenylpyrazole derivatives
11/29/2007US20070276027 Crystalline Forms of [R-(R* ,R*)]-2-(4-Fluorophenyl)-Beta, -Dihydroxy-5-(1-Methylethyl)-3-Phenyl-4-[(Phenylamino)Carbonyl]-1H-Pyrrole-1-Heptanoic Acid
11/29/2007US20070276022 Optically Active Carboxamides
11/29/2007US20070275980 Amide Derivatives, Process For Preparation Thereof And Use Thereof As Insecticide
11/29/2007US20070275956 Novel Heterocyclic Compounds
11/29/2007US20070275371 Colorimetric sensor using polydiacetylene supramolecule
1 ... 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 ... 404